Here are four notes:
1. The GEBT is intended for measurements of the rate of solid-phase gastric emptying.
2. The GEBT also enables the rapid diagnosis of gastroparesis.
3. The test is non-radioactive and non-invasive and can be administered conveniently at a physician’s office, a laboratory collection center or in a tertiary care setting.
4. The Cairn GEBT has been approved by the FDA.
More articles on GI/endoscopy:
4 GI physicians in the news — March 25, 2016
Dr. Gregory Scheible 1st in Indiana to implant Orbera intragastric balloon: 4 points
Emails show Olympus hiked up duodenoscope price 28% after CRE outbreak at UCLA: 8 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.